Trial Profile
A Double Blind Crossover Trial of Levetiracetam (Keppra) and Placebo in the Treatment of Restless Legs Syndrome (RLS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2009 New trial record